Exploring the potential of short-acting immune checkpoint blockers in the therapy of sepsis

Research unit

INNOSUISSE

Project number

118.041 IP-LS

Project title

Exploring the potential of short-acting immune checkpoint blockers in the therapy of sepsis

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Human medicine
Abstract (English)	Sepsis is a life-threatening disease lacking effective treatment options. Based on our scientific discovery, we have developed an innovative therapy that targets the dysfunctional host response. This project aims to validate our lead compound and establish its efficacy in preclinical sepsis models.